The following message was updated on 11/24/2020 1:21:26 AM.
Stand Pat Day; Close $0.285; 326k; SVA is a bargain :)
Mr. House Positions:
Yes, it was good that the local CTV station in London, Ontario (birthplace of Insulin by Banting and Best) took an interest in Sernova and it's formidable functional cure for diabetes. I repeat the link below.
The interview mirrored the last news release being very low key and non-promotional. This allows some upside later once details are released. "When?" is always a valid question to which I have no answer. That said, the three months extension for the warrants suggests imminently. Once we are more than a week into December, I don't expect much to happen. Further, with Thursday being American Thanksgiving, we have another dead spot in the timeline. That leaves a few weeks in January only. "Tempus Fugit".
Regarding a cure for diabetes, at present, there are treatments only. There is no cure for diabetes.
The results from the five cohorts with The Pouch are World First and World Class. It is the closest yet to a cure and the world needs something this good as diabetes is a bigger health problem overall than COVID-19 (even though the latter is getting all the press... new kid on the block).
Big Pharma is figuratively like a supertanker. It is slow to change direction, but once changing, it is slow to do another change. My take is Sernova is just now being noticed (from the results) and Big Pharma is starting to change direction. Once that happens, it will be like a stampede as many then want to climb on the bandwagon even though at present, seemingly, none are.
Sernova isn't a one trick pony. As a minimum, Sernova has five tricks up its sleeve: a functional cure for 1) diabetes, 2) hemophilia A, 3) thyroid disease, 4) possibly several other human ailments like Parkinson's and 5) how to avoid using immunosuppression.
Considering that Vertex swallowed SEMMA for U$950 million (C$4 to $5/SVA share) where SEMMA didn't even have diabetes nailed down and there were no tests on people, Sernova looks like a $$$$$ bargain at that price.
Today, the computers were busy, but Integral Wealth (017) was up to the task to add some sanity to SVA's market trades. Further, 017 seems to not need to trade near as many shares as Mackie (083) did to keep order (which Mackie was usually unable to do). Funny, 017 is like a policeman handing out speeding tickets and is successful at keeping the speeders inline, which I really like!
Even though the general markets were firm, the best SVA could do was stand pat. It closed at $0.285 on a decent 326k (132k Germany; 37k US).